DEF 14A

Company

Cellectar Biosciences, Inc.

Filed

October 2, 2023

Period of Report

October 25, 2023

Accession Number

0001104659-23-105926

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →